Publications

  1. Sarfani S, Scrabeck T, Kearns AE, Berger RA, Kakar S. Clinical efficacy of a fragility care program in distal radius fracture patients. J Hand Surg Am. 2014 Apr; 39(4):664-9. Epub 2014 Feb 25.
    View PubMed
  2. Farr JN, Khosla S, Miyabara Y, Miller VM, Kearns AE. Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women. J Clin Endocrinol Metab. 2013 Feb; 98(2):E249-57. Epub 2013 Jan 15.
    View PubMed
  3. Dy BM, Grant CS, Wermers RA, Kearns AE, Huebner M, Harmsen WS, Thompson GB, Farley DR, Richards ML. Changes in bone mineral density after surgical intervention for primary hyperparathyroidism. Surgery. 2012 Dec; 152(6):1051-8. Epub 2012 Oct 03.
    View PubMed
  4. Miyabara Y, Holmes D 3rd, Camp J, Miller VM, Kearns AE. Comparison of calibrated and uncalibrated bone mineral density by CT to DEXA in menopausal women. Climacteric. 2012 Aug; 15(4):374-81. Epub 2011 Dec 17.
    View PubMed
  5. Espiritu RP, Kearns AE, Vickers KS, Grant C, Ryu E, Wermers RA. Depression in primary hyperparathyroidism: prevalence and benefit of surgery. J Clin Endocrinol Metab. 2011 Nov; 96(11):E1737-45. Epub 2011 Sep 14.
    View PubMed
  6. Miyabara Y, Camp J, Holmes D 3rd, Lahr B, Bailey K, Miller VM, Kearns AE. Coronary arterial calcification and thoracic spine mineral density in early menopause. Climacteric. 2011 Aug; 14(4):438-44. Epub 2011 Jan 25.
    View PubMed
  7. Davidge Pitts CJ, Kearns AE. Update on medications with adverse skeletal effects. Mayo Clin Proc. 2011 Apr; 86(4):338-43; quiz 343. Epub 2011 Mar 9.
    View PubMed
  8. Seeman E, Delmas PD, Hanley DA, Sellmeyer D, Cheung AM, Shane E, Kearns A, Thomas T, Boyd SK, Boutroy S, Bogado C, Majumdar S, Fan M, Libanati C, Zanchetta J. Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. J Bone Miner Res. 2010 Aug; 25(8):1886-94.
    View PubMed
  9. Kearns AE, Northfelt DW, Dueck AC, Atherton PJ, Dakhil SR, Rowland KM Jr, Fuloria J, Flynn PJ, Dentchev T, Loprinzi CL. Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. Support Care Cancer. 2010 Mar; 18(3):321-8. Epub 2009 May 27.
    View PubMed
  10. Melton LJ 3rd, Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Leibson CL. Secular trends in hip fracture incidence and recurrence. Osteoporos Int. 2009 May; 20(5):687-94. Epub 2008 Sep 17.
    View PubMed
  11. Kearns AE, Kallmes DF. Osteoporosis primer for the vertebroplasty practitioner: expanding the focus beyond needles and cement. AJNR Am J Neuroradiol. 2008 Nov; 29(10):1816-22. Epub 2008 Sep 03.
    View PubMed
  12. Chow JT, Khosla S, Melton LJ 3rd, Atkinson EJ, Camp JJ, Kearns AE. Abdominal aortic calcification, BMD, and bone microstructure: a population-based study. J Bone Miner Res. 2008 Oct; 23(10):1601-12.
    View PubMed
  13. Kearns AE, Khosla S, Kostenuik PJ. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev. 2008 Apr; 29(2):155-92. Epub 2007 Dec 05.
    View PubMed
  14. Wermers RA, Kearns AE, Jenkins GD, Melton LJ 3rd. Incidence and clinical spectrum of thiazide-associated hypercalcemia. Am J Med. 2007 Oct; 120(10):911.e9-15. Epub 2007 Apr 16.
    View PubMed
  15. Hallanger Johnson JE, Kearns AE, Doran PM, Khoo TK, Wermers RA. Fluoride-related bone disease associated with habitual tea consumption. Mayo Clin Proc. 2007 Jun; 82(6):719-24.
    View PubMed
  16. From AM, Hyder JA, Kearns AM, Bailey KR, Pellikka PA. Relationship between low bone mineral density and exercise-induced myocardial ischemia. Mayo Clin Proc. 2007 Jun; 82(6):679-85.
    View PubMed
  17. Wermers RA, Hurley DL, Kearns AE. Osteoporosis associated with megestrol acetate. Mayo Clin Proc. 2004 Dec; 79(12):1557-61.
    View PubMed
  18. Kearns AE, Khosla S. Potential anabolic effects of androgens on bone. Mayo Clin Proc. 2004 Apr; 79(4 Suppl):S14-8.
    View PubMed
  19. Modder UI, Sanyal A, Kearns AE, Sibonga JD, Nishihara E, Xu J, O'Malley BW, Ritman EL, Riggs BL, Spelsberg TC, Khosla S. Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice. Endocrinology. 2004 Feb; 145(2):913-21. Epub 2003 Oct 16.
    View PubMed
  20. Kearns AE. Primary hyperparathyroidism: is there anything new? Compr Ther. 2004; 30(2):105-10.
    View PubMed
  21. Kearns AE, Thompson GB. Medical and surgical management of hyperparathyroidism. Mayo Clin Proc. 2002 Jan; 77(1):87-91.
    View PubMed
  22. Kearns AE, Donohue MM, Sanyal B, Demay MB. Cloning and characterization of a novel protein kinase that impairs osteoblast differentiation in vitro. J Biol Chem. 2001 Nov 9; 276(45):42213-8. Epub 2001 Aug 10.
    View PubMed
  23. Kearns AE, Demay MB. BMP-2 induces expression of activin BA and fillistatin in vitro. J Cell Biochem, 2000; 79:80-88.
  24. Kearns AE, Goff DC, Hayden DL, Daniels GH. Risperidone-associated hyperprolactinemina. Endo Practice, 2000; 6:425-429.
  25. Kearns AE, Goto K, Gianakakos G, Lippmann W, Demay MB. Transcriptional repression of the rat osteocalcin gene: role of two intronic CCTCCT motifs. Endocrinology. 1999 Sep; 140(9):4120-6.
    View PubMed
  26. Kearns AE, Vertel BM, Schwartz NB. Topography of glycosylation and UDP-xylose production. J Biol Chem. 1993 May 25; 268(15):11097-104.
    View PubMed
  27. Vertel BM, Walters LM, Flay N, Kearns AE, Schwartz NB. Xylosylation is an endoplasmic reticulum to Golgi event. J Biol Chem. 1993 May 25; 268(15):11105-12.
    View PubMed
  28. Ng K, D'Souza M, Callahan L, Geller DH, Kearns AE, Lyle S, Schwartz NB. Synthesis and utilization of a nonhydrolyzable phosphoadenosine phosphosulfate analog. Anal Biochem. 1991 Oct; 198(1):60-7.
    View PubMed
  29. Kearns AE, Campbell SC, Westley J, Schwartz NB. Initiation of chondroitin sulfate biosynthesis: a kinetic analysis of UDP-D-xylose: core protein beta-D-xylosyltransferase. Biochemistry. 1991 Jul 30; 30(30):7477-83.
    View PubMed